Castanea sativa Mill.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | C. vulgaris Lam. |
| Family | Fagaceae. |
| Habitat | Darjeeling, Khasi Hills, Punjab and Himachal Pradesh. |
| English | Spanish Chestnut, Sweet Chestnut. |
| Folk | Singhaaraa (not to be confused with water-chestnut, Tripa natans L.) |
| Action | Leaves—astringent, antitussive and febrifuge (used for fevers and diseases of the respiratory tract). An infusion is used as a gargle in pharyngitis, proxysmal coughs, catarrh and whooping cough. Nuts—extract, as platelet inhibitor in thrombosis and atherosclerosis. |
| Taxonomic Cohort | Genus Castanea (1 documented species); Family Fagaceae (5 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Castanea sativa (taxonomically cited with authority Mill.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Fagaceae (primary family classification: Fagaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. vulgaris Lam, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Darjeeling, Khasi Hills, Punjab and Himachal Pradesh.
Across classical and vernacular Indian systems of medicine, Castanea sativa is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Spanish Chestnut, Sweet Chestnut; in regional Indian folk and vernacular ethnobotany as Singhaaraa (not to be confused with water-chestnut, Tripa natans L.). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Castanea sativa are: Leaves—astringent, antitussive and febrifuge (used for fevers and diseases of the respiratory tract). An infusion is used as a gargle in pharyngitis, proxysmal coughs, catarrh and whooping cough. Nuts—extract, as platelet inhibitor in thrombosis and atherosclerosis. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Castanea sativa establish the following evidence base: The leaves contain tannins (8–9%) flavone glycosides, triterpenoids, ursolic acid, lupeol and betulin. Heartwood contains 61.4% tannins and 25.7% nontannins. The wood and bark contain 7– 14 and 8–14% tannins respectively. Nuts are eaten raw, roasted or boiled like potatoes. Nuts contain protein, calcium, phosphorus, thiamine, riboflavin and niacin; also tocopherols. Nuts, crushed with vinegar and barley flour, are used against indurations of breast. The extract of nuts exhibits possibility of its use as a platelet inhibitor in thrombosis and atherosclerosis. Leaves are inhibitors of pectinolytic enzymes. American chestnut and European chestnut are equated with Castanea dentata and C. sativa,respectively. Both are used for respiratory ailments.

Botanical Reference 1: Sweet chestnut — Botanical specimen

Botanical Reference 2: Sweet chestnut — Botanical specimen

Botanical Reference 3: Castanea sativa — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Castanea sativa stands as a distinct representative of the genus Castanea. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Fagaceae encompasses 5 documented medicinal species (0.28% of the 1,814-species flora). Other representative medicinal members of Fagaceae include: Fagus sylvatica (European Beech), Quercus ilex (Maayaaphala), Quercus incana (Grey Oak), Quercus infectoria (Maajuphalaka). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 5 medicinal species of family Fagaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Castanea sativa follow the plant-part modalities specified under its therapeutic action (Leaves—astringent, antitussive and febrifuge (used for fevers and diseases of the respiratory tract). An infusion is used as a gargle in pharyngitis, proxysmal coughs, catarrh and whooping cough. Nuts—extract, as platelet inhibitor in thrombosis and atherosclerosis), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Castanea sativa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.